{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:46:44Z","timestamp":1761662804443},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.diagmicrobio.2009.09.012","type":"journal-article","created":{"date-parts":[[2009,10,16]],"date-time":"2009-10-16T04:30:41Z","timestamp":1255667441000},"page":"187-194","source":"Crossref","is-referenced-by-count":13,"title":["In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints"],"prefix":"10.1016","volume":"66","author":[{"given":"Joseph","family":"Papaparaskevas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonidas S.","family":"Tzouvelekis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanassios","family":"Tsakris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore E.","family":"Pittaras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Legakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2009.09.012_bib1","series-title":"Performance standards for antimicrobial susceptibility testing: 19th informational supplement (M100-S19)","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2009"},{"key":"10.1016\/j.diagmicrobio.2009.09.012_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.diagmicrobio.2007.09.017","article-title":"Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta-lactamase\u2013producing Klebsiella pneumoniae epidemic clone","volume":"60","author":"Cobo","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.09.012_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.diagmicrobio.2005.05.004","article-title":"Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia","volume":"52","author":"Fritsche","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.09.012_bib4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.diagmicrobio.2007.10.017","article-title":"Tigecycline activity tested against 11,808 bacterial pathogens recently collected from US medical centers","volume":"60","author":"Gales","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.09.012_bib5","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1469-0691.2006.01621.x","article-title":"Tigecycline: in-vitro performance as a predictor of clinical efficacy","volume":"13","author":"Hawkey","year":"2007","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2009.09.012_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/mdr.2006.9990","article-title":"RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae","volume":"13","author":"Keeney","year":"2007","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.diagmicrobio.2009.09.012_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jac\/dkm397","article-title":"MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli","volume":"61","author":"Keeney","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.09.012_bib8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/jac\/dkn311","article-title":"Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies","volume":"62","author":"Kelesidis","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.09.012_bib9","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1128\/AAC.00155-06","article-title":"Antibiotic co-resistance in extended-spectrum-\u03b2-lactamase\u2013producing Enterobacteriaceae and in vitro activity of tigecycline","volume":"50","author":"Morosini","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.09.012_bib10","first-page":"3284","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe, 1998\u20132005","volume":"12","author":"Muller","year":"2007","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.diagmicrobio.2009.09.012_bib11","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/jac\/dkm391","article-title":"In vitro activity of tigecycline against metallo-beta-lactamase\u2013producing Enterobacteriaceae","volume":"60","author":"Pliatsika","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.09.012_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1469-0691.2007.01943.x","article-title":"Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial","volume":"14","author":"Rodloff","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2009.09.012_bib13","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1128\/AAC.00065-07","article-title":"Evaluation of tigecycline penetration into colon wall tissue and epithelial lining fluid using a population pharmacokinetic model and Monte Carlo simulation","volume":"51","author":"Rubino","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.09.012_bib14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/AAC.49.3.1017-1022.2005","article-title":"Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae","volume":"49","author":"Ruzin","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.09.012_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.diagmicrobio.2005.05.005","article-title":"Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents","volume":"52","author":"Sader","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.09.012_bib16","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1128\/AAC.00322-06","article-title":"In vitro activity of tigecycline against multiple-drug\u2013resistant, including pan-resistant, gram-negative and gram-positive clinical isolates from Greek hospitals","volume":"50","author":"Souli","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.09.012_bib17","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1469-0691.2006.01578.x","article-title":"EUCAST technical note on tigecycline","volume":"12","author":"The European Antimicrobial Susceptibility Testing (EUCAST) Steering Committee","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2009.09.012_bib18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jac\/dkm459","article-title":"In vitro activities of tigecycline combined with other antimicrobials against multiresistant Gram-positive and Gram-negative pathogens","volume":"61","author":"Vouillamoz","year":"2008","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889309003770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889309003770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T19:56:35Z","timestamp":1544903795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889309003770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0732889309003770"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2009.09.012","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}